FDA Panel Backs Peptides, Legal Access Still Uncertain
#Peptides #FDAFDA panel backed seven peptides despite safety concerns, but availability remains uncertain. Compounding pharmacies may gain approval via Category One list, though timelines vary. Demand outpaces evidence, and prescriptions would require pharmacies to prepare them. read more
FDA Weighs Peptide Access Amid Kennedy Push and Scientist Warnings
#FDA #PeptidesThe FDA may approve unproven peptide injections pushed by Health Secretary RFK Jr., who says he uses them. Scientists warn of lacking evidence and safety data. An advisory committee meets Thursday to decide on seven peptides previously banned. read more
FDA panel weighs lifting peptide therapy restrictions
#FDA #PeptidesAn FDA advisory panel reviews seven popular peptides like TB-500 and BPC-157 for compounding pharmacy access, despite lacking large-scale human trials. Proponents cite benefits for recovery and metabolism, while scientists warn of limited data and safety risks. read more
FDA Scientists Warn Against RFK Jr.-Backed Peptides
#Peptides #FDASafetyFDA scientists flag safety concerns over synthetic peptides like BPC-157, citing insufficient evidence for health benefits. Health Secretary RFK Jr. supports loosening restrictions, but career staff recommend caution amid rising popularity and grey market sourcing. read more